Pembrolizumab enhances progression-free survival in patients with locally advanced cervical cancer
1. Progression-free survival at 24 months was higher in the pembrolizumab versus...
Read MoreMay 1, 2024
1. Progression-free survival at 24 months was higher in the pembrolizumab versus...
Read MoreApr 30, 2024
1. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation...
Read MoreApr 30, 2024
1. The median overall survival was 17.6 months in the gefitinib group vs 27.5 months in the...
Read MoreApr 30, 2024
Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly...
Read MoreApr 28, 2024
1. In a cohort of patients with varying lung function assessed through values of FVC and FEV1, and...
Read MoreApr 25, 2024
1. In this randomized controlled trial, long-term beta-blockers did not impact all-cause mortality...
Read MoreApr 24, 2024
1. In this randomized controlled trial, semaglutide was more effective in reducing heart...
Read MoreApr 23, 2024
1. Mitoxantrone enhances five-year event-free survival over liposomal daunorubicin in MRD-guided...
Read MoreApr 16, 2024
1. When compared to upfront surgery, neoadjuvant chemotherapy using mFOLFOX or CAPOX did not...
Read MoreApr 16, 2024
1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion...
Read MoreApr 12, 2024
1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score...
Read MoreApr 11, 2024
1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable...
Read MoreApr 10, 2024
1. Intravascular imaging-guided PCI significantly reduces target lesion failure compared to...
Read MoreApr 9, 2024
1. Roughly 65% of the cancer medication budget is allocated to treatments that provide improvement...
Read MoreApr 9, 2024
1. The pathological response rate had an OR of 3.16 when comparing neoadjuvant dual vs single...
Read MoreApr 8, 2024
1. Patients randomized to receive the paravertebral block (PVB) and erector spinae plane block...
Read MoreApr 6, 2024
1. In this randomized controlled trial, omalizumab was superior to placebo in increasing the...
Read MoreApr 6, 2024
1. This retrospective study found that the use of medications for alcohol use disorder (MAUD)...
Read MoreApr 4, 2024
1. In this cohort study, neutralizing autoantibodies against interleukin-23 (anti-IL-23) were...
Read MoreApr 3, 2024
1. In this prospective study, patients with carotid artery stenosis with microplastics and...
Read More